0001811466-20-000002.txt : 20200929 0001811466-20-000002.hdr.sgml : 20200929 20200928182340 ACCESSION NUMBER: 0001811466-20-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200929 DATE AS OF CHANGE: 20200928 EFFECTIVENESS DATE: 20200929 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Viridian Therapeutics, Inc. CENTRAL INDEX KEY: 0001811466 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-376545 FILM NUMBER: 201205537 BUSINESS ADDRESS: STREET 1: 203 CRESCENT STREET STREET 2: BUILDING 17, SUITE #102B CITY: WALTHAM STATE: MA ZIP: 02453 BUSINESS PHONE: 919-949-8552 MAIL ADDRESS: STREET 1: 203 CRESCENT STREET STREET 2: BUILDING 17, SUITE #102B CITY: WALTHAM STATE: MA ZIP: 02453 D 1 primary_doc.xml X0708 D LIVE 0001811466 Viridian Therapeutics, Inc. 203 CRESCENT STREET BUILDING 17, SUITE #102B WALTHAM MA MASSACHUSETTS 02453 919-949-8552 DELAWARE None None Corporation true 2020 Jonathan Violin c/o Viridian Therapeutics, Inc. 203 Crescent Street, Bld 17, Ste #102B Waltham MA MASSACHUSETTS 02453 Executive Officer Director Tomas Kiselak c/o Viridian Therapeutics, Inc. 203 Crescent Street, Bld 17, Ste #102B Waltham MA MASSACHUSETTS 02453 Director Peter Harwin c/o Viridian Therapeutics, Inc. 203 Crescent Street, Bld 17, Ste #102B Waltham MA MASSACHUSETTS 02453 Director Biotechnology Decline to Disclose 06b false 2020-09-17 false true false 0 27000000 27000000 0 false 9 0 0 0 false Viridian Therapeutics, Inc. /s/ Jonathan Violin Jonathan Violin President and Chief Executive Officer 2020-09-25